Clinical Trial Update: Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant atezolizumab plus bevacizumab before surgery for resectable hepatocellular carcinoma; the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING